Laura Elizabeth Gould

Laura Elizabeth Gould

Auto-generated profile, based on publicly available information

Laura Elizabeth Gould


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 August 2022 in International Journal of Surgery
Verified
Journal Article
Closed access
LGLaura E. Gould
Laura E. Gould
EPEdward T. Pring
Edward T. Pring
IDIoanna Drami
Ioanna Drami
MMMorgan Moorghen
Morgan Moorghen
MNMani Naghibi
Mani Naghibi
CRCampbell Sd. Roxburgh
Campbell Sd. Roxburgh
Despite multimodal therapy 5-15% of patients who undergo resection for advanced rectal cancer (LARC) will develop local recurrence. Management of locally recurrent rectal cancer (LRRC) presents a significant therapeutic challenge and even with modern exenterative surgery, 5-year survival rates are poor at 25-50%. High rates of local and systemic recurrence in this cohort are reflective of the likely biological aggressiveness of these tumour types. This review aims to appraise the current literature identifying pathological factors associated with survival and tumour recurrence in patients undergoing exenterative surgery. A systematic review was carried out searching MEDLINE, EMBASE and COCHRANE Trials database for all studies assessing pathological factors influencing survival following pelvic exenteration for LARC or LRRC from 2010 to July 2021 following PRISMA guidelines. Risk of bias was assessed using QUIPS tool. Nine cohort studies met inclusion criteria, reporting outcomes for 2864 patients. Meta-analysis was not possible due to significant heterogeneity of reported outcomes. Resection margin status and nodal disease were the most commonly reported factors. A positive resection margin was demonstrated to be a negative prognostic marker in six studies. Involved lymph nodes and lymphovascular invasion also appear to be negative prognostic markers with tumour stage to be of lesser importance. No studies assessed other adverse tumour features that would not otherwise be included in a standard histopathology report. Pathological resection margin status is widely demonstrated to influence disease free and overall survival following pelvic exenteration for rectal cancer. With increasing R0 rates, other adverse tumour features must be explored to help elucidate differences in survival and potentially guide tailored oncological treatment.

28 April 2025 in Abdominal Radiology
Verified
Journal Article
Open access
PDF file
JRJason Rai
Jason Rai
DMDinh V. C. Mai
Dinh V. C. Mai
IDIoanna Drami
Ioanna Drami
EPEdward Pring
Edward Pring
LGLaura E. Gould
Laura E. Gould
JJJohn T Jenkins
John T Jenkins
Purpose: Predicting response to neoadjuvant therapy in locally advanced rectal cancer (LARC) is challenging. Organ preservation strategies can be offered to patients with complete clinical response. We aim to evaluate MRI-derived radiomics models in predicting complete pathological response (pCR). Methods: Search included MEDLINE, Embase and Cochrane Central Register of Controlled Trials (CENTRAL) and Cochrane Database of Systematic Reviews (CDSR) for studies published before 1st February 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) and Radiomics Quality Score (RQS) tools were used to assess quality of included study. The research protocol was registered in PROSPERO (CRD42024512865). We calculated pooled area under the receiver operating characteristic curve (AUC) using a random-effects model. To compare AUC between subgroups the Hanley & McNeil test was performed. Results: Forty-four eligible studies (12,714 patients) were identified for inclusion in the systematic review. We selected thirty-five studies including 10,543 patients for meta-analysis. The pooled AUC for MRI radiomics predicted pCR in LARC was 0.87 (95% CI 0.84–0.89). In the subgroup analysis 3 T MRI field intensity had higher pooled AUC 0.9 (95% CI 0.87–0.94) than 1.5 T pooled AUC 0.82 (95% CI 0.80–0.83) p < 0.001. Asian ethnicity had higher pooled AUC 0.9 (95% CI 0.87–0.93) than non-Asian pooled AUC 0.8 (95% CI 0.75–0.84) p < 0.001. Conclusion: We have demonstrated that 3 T MRI field intensity provides a superior predictive performance. The role of ethnicity on radiomics features needs to be explored in future studies. Further research in the field of MRI radiomics is important as accurate prediction for pCR can lead to organ preservation strategy in LARC. Graphical

19 March 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
EPEdward Tobias Pring
Edward Tobias Pring
GMGeorge Malietzis
George Malietzis
LGLaura E. Gould
Laura E. Gould
PLPhilip Lung
Philip Lung
IDIoanna Drami
Ioanna Drami
JJJohn T. Jenkins
John T. Jenkins

29 August 2021 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
LGLaura E Gould
Laura E Gould
EPEdward T. Pring
Edward T. Pring
ACAlison Corr
Alison Corr
JFJordan Fletcher
Jordan Fletcher
JWJanindra Warusavitarne
Janindra Warusavitarne
THthe St. Mark’s Retrorectal Study Group, St Mark’s Hospital
the St. Mark’s Retrorectal Study Group, St Mark’s Hospital

28 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
DMDinh Van Chi Mai
Dinh Van Chi Mai
IDIoanna Drami
Ioanna Drami
EPEdward Tobias Pring
Edward Tobias Pring
LGLaura E. Gould
Laura E. Gould
JRJason Rai
Jason Rai
OGon behalf of the BiCyCLE Research Group
on behalf of the BiCyCLE Research Group
Background: A strong body of evidence exists demonstrating deleterious relationships between abnormal body composition (BC) and outcomes in non-complex colorectal cancer. Complex rectal cancer (RC) includes locally advanced and locally recurrent tumours. This scoping review aims to summarise the current evidence examining BC in complex RC. Methods: A literature search was performed on Ovid MEDLINE, EMBASE, and Cochrane databases. Original studies examining BC in adult patients with complex RC were included. Two authors undertook screening and full-text reviews. Results: Thirty-five studies were included. Muscle quantity was the most commonly studied BC metric, with sarcopenia appearing to predict mortality, recurrence, neoadjuvant therapy outcomes, and postoperative complications. In particular, 10 studies examined relationships between BC and neoadjuvant therapy response, with six showing a significant association with sarcopenia. Only one study examined interventions for improving BC in patients with complex RC, and only one study specifically examined patients undergoing pelvic exenteration. Marked variation was also observed in terms of how BC was quantified, both in terms of anatomical location and how cut-off values were defined. Conclusions: Sarcopenia appears to predict mortality and recurrence in complex RC. An opportunity exists for a meta-analysis examining poorer BC and neoadjuvant therapy outcomes. There is a paucity of studies examining interventions for poor BC. Further research examining BC specifically in patients undergoing pelvic exenteration surgery is also lacking. Pitfalls identified include variances in how BC is measured on computed tomography and whether external cut-off values for muscle and adipose tissue are appropriate for a particular study population.